Trial Profile
A phase II clinical trial to investigate the efficacy of BIL010t for the treatment of basal cell carcinoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Jun 2016
Price :
$35
*
At a glance
- Drugs BIL 010t (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 02 Jun 2016 The company plans to begin this trial in 2016, according to a Biosceptre media release.
- 02 Jun 2016 New trial record